Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6697751 | 7373509 | I | 6697751-5 | 20080801 | 20100416 | 20100423 | EXP | TPA2009A03785 | TAKEDA PHARMACEUTICALS NORTH AMERICA | 77 | YR | M | N | 180 | LBS | 20100422 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6697751 | 1013572856 | PS | ACTOS | 1 | ORAL | 30 MG, 1 IN 1 D, PER ORAL | Y | D | 21073 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6697751 | 1013572856 | TYPE 2 DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6697751 | HO |
| 6697751 | LT |
| 6697751 | OT |
| 6697751 | RI |
Reactions reported
| Event ID | PT |
|---|---|
| 6697751 | MYOCARDIAL INFARCTION |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6697751 | CSM |
| 6697751 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6697751 | 1013572856 | 20030421 | 20080925 |